Alexion Pharmaceuticals Takes Over #30 Spot From Danaher
September 10, 2015 at 11:47 AM EDT
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Alexion Pharmaceuticals Inc. (ALXN) has taken over the #30 spot from Danaher Corp..